SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19

Overview of attention for article published in Pharmacological Research, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter: 95 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 113 X posts from 95 X users, with an upper bound of 365,893 followers.

Study of the SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19: https://t.co/ifQS90OdFC #SARSCoV2 #mithocondria #epigenoma #PharmacolRes #openaccess #Research #PharmaTwitter #MedTwitter https://t.co/fevZrpqk1X

20 May 2024

Reply Repost Favourite

Yet @GOP SILENT @DNC SILENT

09 May 2024

Reply Repost Favourite

RT @kelrobi11: @KLVeritas Thank you Kat. #ExitTheWHO Looking for pathogens and then enhancing them to sell vaccines is a terrible idea. SAR…

09 May 2024

Reply Repost Favourite

@KLVeritas Thank you Kat. #ExitTheWHO Looking for pathogens and then enhancing them to sell vaccines is a terrible idea. SARS-CoV-2 appears to silence OXPHOS gene expression and restructure DNA related to metabolism. This is one more way it causing fatigue

09 May 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 109 additional X posts.